Allogene Therapeutics, Inc. (ALLO): Cash & Equivalents
$51.69M
As of 2025-12-31
$38.63M
As of 2026-06-30
-5.8%
3-year compound annual growth
-22.4%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.69M | -31.3% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $75.22M | -9.5% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $83.16M | n/a | 2025-03-13, Balance as of period end |
| 2023-09-30 | $69.25M | n/a | 2024-03-14, Balance as of period end |
| 2023-06-30 | $154.76M | n/a | 2024-03-14, Balance as of period end |
| 2023-03-31 | $109.93M | n/a | 2024-03-14, Balance as of period end |
| 2022-12-31 | $61.90M | n/a | 2024-03-14, Balance as of period end |
| 2022-09-30 | $74.36M | n/a | 2024-03-14, Balance as of period end |
| 2022-06-30 | $96.04M | n/a | 2024-03-14, Balance as of period end |
| 2022-03-31 | $84.51M | n/a | 2024-03-14, Balance as of period end |
| 2021-12-31 | $173.31M | -5.5% | 2024-03-14, Balance as of period end |
| 2020-12-31 | $183.35M | +4.7% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $175.13M | +89.5% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $92.43M | n/a | 2020-02-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | 2025-12-31 | $51.69M | -31.3% |
| Amgen Inc (AMGN) | 2025-12-31 | $9.13B | -23.8% |
| Repligen Corp (RGEN) | 2025-12-31 | $566.02M | -25.3% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $264.71M | +63.2% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $40.79M | -10.9% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $89.74M | -14.3% |
| Vericel Corp (VCEL) | 2025-12-31 | $100.09M | +34.3% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $713.00M | +206.0% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $482.49M | +122.0% |
Compare ALLO, AMGN, RGEN, TECH side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗